Search Results

Displaying Results 226-250 of 302 "'SV'"

Sep 13, 2025, 14:17 ET Desay SV Shines at IAA Mobility with "In Europe, with Europe, for All" Concept

Sept. 13, 2025 /PRNewswire/ -- During Sept. 8-12, 2025, Desay SV, a leading automotive intelligence product supplier, made a notable appearance at IAA Mobility, presenting the regional concept of "In Europe, with

More news about: Desay SV


Sep 12, 2025, 10:00 ET Dow Jones och Cision löser pågående tvist

View original content:https://www.prnewswire.com/sv/pressmeddelanden/dow-jones-och-cision-loser-pagaende-tvist-302555187.html

More news about: Cision Ltd.


Sep 12, 2025, 03:00 ET Metal Logic lanserar en modulär och skalbar lågemissionsplattform för smältning, med första etableringsplatsen säkrad i Pilbara-regionen

content:https://www.prnewswire.com/sv/pressmeddelanden/metal-logic-lanserar-en-modular-och-skalbar-lagemissionsplattform-for-smaltning-med-forsta-etableringsplatsen-sakrad-i-pilbara-regionen-302554486.html

More news about: Metal Logic


Sep 11, 2025, 12:25 ET Psoriasissjukdom sätts i fokus vid FN:s generalförsamling: IFPA uppmanar till att höja statusen för psoriasissjukdom under FN:s högnivåmöten

content:https://www.prnewswire.com/sv/pressmeddelanden/psoriasissjukdom-satts-i-fokus-vid-fns-generalforsamling-ifpa-uppmanar-till-att-hoja-statusen-for-psoriasissjukdom-under-fns-hognivamoten-302554198.html

More news about: IFPA


Sep 10, 2025, 17:43 ET Shield AI öppnar kontor i Oslo för att stärka sina partnerskap med den norska försvarsindustrin och NATO-allierade

content:https://www.prnewswire.com/sv/pressmeddelanden/shield-ai-oppnar-kontor-i-oslo-for-att-starka-sina-partnerskap-med-den-norska-forsvarsindustrin-och-nato-allierade-302553199.html

More news about: Shield AI


Sep 10, 2025, 06:54 ET Vantage markerar en stark närvaro på Crypto Latin Fest 2025 i Medellín

content:https://www.prnewswire.com/sv/pressmeddelanden/vantage-markerar-en-stark-narvaro-pa-crypto-latin-fest-2025-i-medellin-302552383.html

More news about: Vantage


Sep 10, 2025, 01:00 ET EGN, ett Vistage-företag, utser Rikke Lolk Fjeldsted till VD för att leda nästa tillväxtfas

content:https://www.prnewswire.com/sv/pressmeddelanden/egn-ett-vistage-foretag-utser-rikke-lolk-fjeldsted-till-vd-for-att-leda-nasta-tillvaxtfas-302551619.html

More news about: Vistage Worldwide, Inc.


Sep 09, 2025, 03:00 ET Alchemab Therapeutics initiates Phase 1 clinical trial of ATLX-1282 and announces Series A financing extension

included participation from Ono Venture Investment (OVI) alongside a blue-chip syndicate of existing specialist investors which includes RA Capital, SV Health Investors, DCVC Bio and Lightstone Ventures and strategic investment by Lilly.  Alchemab's proprietary, AI-enabled platform is transforming

More news about: Alchemab Therapeutics


Sep 08, 2025, 15:08 ET Universal Robots presenterar UR8 Long: Konstruerad att klara automationsuppgifter i de mest krävande miljöer och trånga utrymmen

content:https://www.prnewswire.com/sv/pressmeddelanden/universal-robots-presenterar-ur8-long-konstruerad-att-klara-automationsuppgifter-i-de-mest-kravande-miljoer-och-tranga-utrymmen-302549699.html

More news about: Universal Robots


Sep 04, 2025, 16:46 ET Together AI fortsätter sin europeiska expansion: Infrastruktur som nu finns och fungerar i Sverige

content:https://www.prnewswire.com/sv/pressmeddelanden/together-ai-fortsatter-sin-europeiska-expansion-infrastruktur-som-nu-finns-och-fungerar-i-sverige-302547109.html

More news about: Together AI


Sep 03, 2025, 06:00 ET DeepL presenterar autonom AI-agent för företag

original content:https://www.prnewswire.com/sv/pressmeddelanden/deepl-presenterar-autonom-ai-agent-for-foretag-302543988.html

More news about: DeepL


Sep 02, 2025, 10:00 ET Cision utnämner Gianna Jackson till Chief Revenue Officer för Amerika

content:https://www.prnewswire.com/sv/pressmeddelanden/cision-utnamner-gianna-jackson-till-chief-revenue-officer-for-amerika-302542726.html

More news about: Cision Ltd.


Sep 02, 2025, 09:05 ET Bauer Hockey utnämner Gillian Meek som EVP och General Manager

content:https://www.prnewswire.com/sv/pressmeddelanden/bauer-hockey-utnamner-gillian-meek-som-evp-och-general-manager-302542717.html

More news about: Bauer


Aug 29, 2025, 10:44 ET Expert Panel to Discuss Innovations in Alzheimer's Disease Clinical Trials

Expert panelists: Dr. Ruth McKernan, FMEdSci CBE, Operating Partner, SV Health Investors, CEO, Draig Therapeutics and Chair, Cumulus NeuroscienceProfessor James Rowe, BA BMBCh FRCP

More news about: Xtalks


Aug 29, 2025, 03:42 ET ZINZINO AB (PUBL.): INTERIM REPORT FOR THE SECOND QUARTER OF 2025

https://www.zinzino.com/site/SE/sv-SE/om-oss/investerare/ For more information:Dag Bergheim Pettersen, CEO, Zinzino, +47 (0)

More news about: Zinzino


Aug 29, 2025, 03:33 ET ZINZINO AB (PUBL.): INTERIM REPORT FOR THE SECOND QUARTER OF 2025

https://www.zinzino.com/site/SE/sv-SE/om-oss/investerare/ For more information:Dag Bergheim Pettersen, CEO, Zinzino, +47 (0)

More news about: Zinzino


Aug 28, 2025, 08:30 ET Innovations in Alzheimer's Disease Clinical Trials: Digital Endpoints - Upcoming Expert Panel Discussion Hosted by Xtalks

Expert panelists: Dr. Ruth McKernan, FMEdSci CBE, Operating Partner, SV Health Investors, CEO, Draig Therapeutics and Chair, Cumulus NeuroscienceProfessor James Rowe, BA BMBCh FRCP

More news about: Xtalks


Aug 27, 2025, 07:00 ET Leal Therapeutics Announces $30 Million Series A to Progress First-In-Class Neuro-Metabolic Therapies for Neurodegenerative and Neuropsychiatric Disorders with High-Unmet Need

information, please visit https://svhealthinvestors.com/DDF. About SV Health Investors SV Health Investors is a leading healthcare fund manager committed to investing in tomorrow's healthcare breakthroughs. The SV funds invest across stages, geographic regions, and sectors, with expertise

More news about: Leal Therapeutics


Aug 25, 2025, 07:00 ET AI Industry Launches "Leading the Future" to Drive U.S. AI Leadership, Economic Growth, National Security, and Innovation

Supporters of the initiative include Andreessen Horowitz, Greg and Anna Brockman, Ron Conway (SV Angel), Joe Lonsdale (8VC), and Perplexity, with other prominent firms and individuals from across the tech and investment

More news about: Leading the Future


Aug 19, 2025, 10:00 ET Keychain Raises $30 Million Series B and Launches KeychainOS, an AI Operating System Set to Power the Future of CPG Manufacturing

consumers love. The company is backed by leading investment firms Lightspeed Venture Partners, BoxGroup, Wellington, SV Angel and industry leaders General Mills, The Hershey Company, Schreiber Foods, and Rich's Food. Keychain has built a network of over 30,000 manufacturers

More news about: Keychain


Aug 18, 2025, 19:00 ET True Global Ventures Beviljas Tillstånd för Kapitalmarknadstjänster av MAS

content:https://www.prnewswire.com/sv/pressmeddelanden/true-global-ventures-beviljas-tillstand-for-kapitalmarknadstjanster-av-mas-302531939.html

More news about: True Global Ventures


Aug 14, 2025, 10:00 ET CisionOne vinner "Best Media Monitoring Solution" för andra året i rad på 2025 MarTech Breakthrough Awards

content:https://www.prnewswire.com/sv/pressmeddelanden/cisionone-vinner-best-media-monitoring-solution-for-andra-aret-i-rad-pa-2025-martech-breakthrough-awards-302529333.html

More news about: Cision Ltd.


Aug 12, 2025, 14:15 ET Post-Hoc FUEL Trial Analysis Shows Udenafil Significantly Improves Exercise Capacity in Fontan Patients with Reduced Baseline Function

udenafil, a PDE5 inhibitor, significantly improves peak oxygen consumption (peak VO₂) in adolescents with single ventricle congenital heart disease (SV-CHD) who have undergone the Fontan procedure and have reduced exercise capacity.

More news about: Mezzion Pharmaceuticals, Inc


Aug 11, 2025, 04:41 ET Vantage lanserar ny videokampanj som visar passion och ambition

content:https://www.prnewswire.com/sv/pressmeddelanden/vantage-lanserar-ny-videokampanj-som-visar-passion-och-ambition-302526306.html

More news about: Vantage


Aug 07, 2025, 08:00 ET Edgewise Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights

June 2025, the Company announced encouraging observations across functional measures, including Stride Velocity 95th Centile (SV95C), NSAA and 4 stair-climb, while identifying a dose of 10 mg to evaluate in Phase 3.  FOX Phase 2 placebo-controlled trial in boys with Duchenne:

More news about: Edgewise Therapeutics


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.